Folgen
Keine Story von Unilabs SA mehr verpassen.

Unilabs SA

Filtern
  • 08.11.2004 – 07:00

    Unilabs reaffirms its growth objectives for 2004/2005

    During the first quarter, Unilabs laboratories achieved: - revenues of CHF 54.8 million (+4.7%) - EBITDA margin of CHF 6.2 million (+18.6%) - EBIT margin of CHF 4.1 million (+29.3%) Geneva (ots) - During the first quarter of the 2004/2005 fiscal year, which ended on 31 August 2004, Unilabs laboratories achieved consolidated revenues of CHF 54.8 million, up 4.7% as compared to the same prior year period, or 5.1% at ...

  • 20.07.2004 – 08:17

    Unilabs signs a new contract for hospital laboratory services

    Geneva (ots) - The Unilabs laboratory in Lugano (Tessin) has signed an agreement with two hospital establishments located in the Lugano area. These hospitals comprise a total of 150 beds and accommodate around 6,500 hospitalized patients and 32,000 outpatients per year. The contract, which takes effect immediately, relates to an estimated annual turnover of CHF 1.5 million and a minimum period of until December 31, ...

  • 08.07.2004 – 07:00

    Unilabs strengthens its position in Switzerland and Spain

    Geneva (ots) - Unilabs announces the signature of an agreement taking effect on August 1st 2004, under the terms of which it is buying an anatomical pathology laboratory located in a Swiss town where it already owns a laboratory specialised in the same field of activity. The annual turnover is around CHF 2 million. Unilabs has also strengthened its position in Spain by winning a tender for the management of the ...

  • 24.06.2004 – 18:12

    Unilabs consolidates its position with the hospitals of the Vaud Riviera

    Geneva (ots) - The hospitals of the Vaud Riviera (Montreux Hospital and Hôpital du Samaritain in Vevey) have just extended their partnership with Unilabs until 2011 by adding a new partner, the Hôpital de la Providence in Vevey. The signature of this agreement confirms the excellent collaboration started in June 2000 with the Hôpital Riviera. The contract ...

  • 09.06.2004 – 07:00

    UNILABS launches a new range of early-stage diagnostic tests in Europe

    Geneva (ots) - Biocheckup tests will allow early detection of signs of illness and permit evaluation of the risk factors for diseases such as diabetes, cancer or cardiovascular disease Most people are concerned by the state of their health and would like to know their predisposition to different pathologies before they become established (e.g. diabetes, cancer, ...